Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
The American Journal of Pathology|July 19, 2015
Stat5a/b in Prostate Cancer MetastasisAllen C Gao, Yezi Zhu
Oncotarget|April 7, 2016
Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancerChengfei Liu, Cameron Armstrong, Yezi Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2015
Antiandrogens Inhibit ABCB1 Efflux and ATPase Activity and Reverse Docetaxel Resistance in Advanced Prostate CancerYezi Zhu, Chengfei Liu, Cameron Armstrong, et al.
The Prostate|May 14, 2014
Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST)Yezi Zhu, Chengfei Liu, Yuanyuan Cui, et al.
The Prostate|August 8, 2013
RhoGDIα downregulates androgen receptor signaling in prostate cancer cellsYezi Zhu, Chengfei Liu, Ramakumar Tummala, et al.
The Prostate|December 6, 2013
Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cellsChengfei Liu, Yezi Zhu, Wei Lou, et al.
The Prostate|May 14, 2015
Niclosamide suppresses cell migration and invasion in enzalutamide resistant prostate cancer cells via Stat3-AR axis inhibitionChengfei Liu, Wei Lou, Cameron Armstrong, et al.
Molecular Cancer Therapeutics|July 18, 2013
Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancerYezi Zhu, Chengfei Liu, Nagalakshmi Nadiminty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2014
Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancerChengfei Liu, Wei Lou, Yezi Zhu, et al.
The Prostate|June 18, 2011
RhoGDIα suppresses growth and survival of prostate cancer cellsYezi Zhu, Ramakumar Tummala, Chengfei Liu, et al.
Pageof 16